Kinarus Therapeutics Holding Ltd
KNRS
ISIN CH0009115129 / Valor 911512
Kinarus Therapeutics Holding Ltd
UMushroom community rating:
About company
Kinarus Therapeutics Holding Ltd is a biopharmaceutical company based in Basel, Switzerland, that focuses on developing novel treatments for patients with viral, respiratory, and ophthalmic diseases. The company's main therapeutic drug candidate, KIN001, is an advanced clinical stage p38 MAPK inhibitor combined with a marketed drug, offering an oral, long-term effective treatment for diseases that significantly impact patients' quality of life. Founded in 2017, Kinarus aims to provide patient-focused solutions to address unmet medical needs in various disease areas.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
1 M
Market cap (USD)
Daily traded volume (Shares)
/
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
